{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:04:55Z","timestamp":1788440695649,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Continuous glucose monitoring (CGM) enhances glycemic control and reduces hypoglycemia in patients with diabetes, but its use in geriatric inpatients remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To assess the feasibility in CGM use among patients hospitalized in an acute geriatric unit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a pilot single-center observational study involving patients aged\u2009\u2265\u200975 years with insulin-treated diabetes who met the French national criteria for CGM reimbursement. The primary endpoint was feasibility of CGM, defined as the acceptability and continuation of CGM during hospitalization with \u2265\u200970% sensor activity. Secondary endpoints included hypoglycemia (&lt;\u200970\u00a0mg\/dL), factors associated with hypoglycemia and hyperglycemia (&gt;\u2009180\u00a0mg\/dL), and the clinical, metabolic, and therapeutic determinants of CGM results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 52 patients (median age 85.5 years; 50% women), 46 (89%) continued CGM during hospitalization and 40 (77%) achieved\u2009\u2265\u200970% sensor activity. A total of 61 hypoglycemic episodes were recorded (mean 1.2 per patient), none of which were symptomatic. Mean time below range (&lt;\u200970\u00a0mg\/dL) was 1.4\u2009\u00b1\u20092.1%, and mean time above range (&gt;\u2009180\u00a0mg\/dL) was 31.9\u2009\u00b1\u200922.4%. Exploratory analyses showed that time above range was positively correlated with bolus (\u03c1\u2009=\u20090.72,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and total daily insulin doses (\u03c1\u2009=\u20090.68,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). At discharge, 38 of the 41 patients (96.7%) who remained on insulin were prescribed CGM. No device-related serious adverse events were observed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CGM use in an acute geriatric unit was feasible and well tolerated, with a high proportion of analyzable sensor data and limited hypoglycemia. These findings support the integration of CGM into routine inpatient geriatric diabetes care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12877-026-07333-w","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T23:53:16Z","timestamp":1773705196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Feasibility of continuous glucose monitoring in an acute geriatric unit \u2013 the GLYCOGER study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7618-690X","authenticated-orcid":false,"given":"Nathana\u00ebl","family":"Bassas Letissier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7360-4209","authenticated-orcid":false,"given":"Helena","family":"Mosbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1862-4252","authenticated-orcid":false,"given":"Pierre-Jean","family":"Saulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Piguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3451-3097","authenticated-orcid":false,"given":"Marc","family":"Paccalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-5064","authenticated-orcid":false,"given":"Evelyne","family":"Liuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"7333_CR1","unstructured":"IDF Diabetes Atlas 10. th Edition. Disponible sur: https:\/\/diabetesatlas.org\/data\/.\u00a0Cit\u00e9 6 janv 2025."},{"key":"7333_CR2","unstructured":"Diabetes Atlas - France. Diabetes Atlas. Disponible sur: https:\/\/diabetesatlas.org\/data-by-location\/country\/france\/. Cit\u00e9 11 d\u00e9c 2025."},{"key":"7333_CR3","unstructured":"Diab\u00e8te. Disponible sur: https:\/\/www.santepubliquefrance.fr\/maladies-et-traumatismes\/diabete. Cit\u00e9 3 janv 2025."},{"issue":"9","key":"7333_CR4","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.2337\/dc07-0295","volume":"30","author":"GE Umpierrez","year":"2007","unstructured":"Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care sept. 2007;30(9):2181\u20136. https:\/\/doi.org\/10.2337\/dc07-0295. PubMed PMID: 17513708.","journal-title":"Diabetes Care sept"},{"issue":"4","key":"7333_CR5","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jdiacomp.2006.02.004","volume":"21","author":"S Nakar","year":"2007","unstructured":"Nakar S, Yitzhaki G, Rosenberg R, Vinker S. Transition to insulin in Type 2 diabetes: family physicians\u2019 misconception of patients\u2019 fears contributes to existing barriers. J Diabetes Complications. 2007;21(4):220\u20136. 02.004 PubMed PMID: 17616351.","journal-title":"J Diabetes Complications"},{"issue":"967","key":"7333_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/pgmj.2005.039545","volume":"82","author":"D Jeavons","year":"2006","unstructured":"Jeavons D, Hungin APS, Cornford CS. Patients with poorly controlled diabetes in primary care: healthcare clinicians\u2019 beliefs and attitudes. Postgrad Med J mai. 2006;82(967):347\u201350. https:\/\/doi.org\/10.1136\/pgmj.2005.039545. PubMed PMID: 16679475; PubMed Central PMCID: PMC2563795.","journal-title":"Postgrad Med J mai"},{"key":"7333_CR7","doi-asserted-by":"publisher","unstructured":"Yk L, Cj N, Py L, Em K, Kl A, Wy L, et al. What are the barriers faced by patients using insulin? A qualitative study of Malaysian health care professionals\u2019 views. Patient Prefer Adherence. 2013;7. https:\/\/doi.org\/10.2147\/PPA.S36791. PubMed PMID: 23378747.","DOI":"10.2147\/PPA.S36791"},{"key":"7333_CR8","unstructured":"Arr\u00eat\u00e9 du 8. juin 2023 portant modification des conditions d\u2019inscription du syst\u00e8me flash d\u2019autosurveillance du glucose FREESTYLE LIBRE 2 de la soci\u00e9t\u00e9 ABBOTT France inscrit au titre Ier de la liste des produits et prestations remboursables pr\u00e9vue \u00e0 l\u2019article L. 165-1 du code de la s\u00e9curit\u00e9 sociale - L\u00e9gifrance. Disponible sur: https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000047670319. Cit\u00e9 9 f\u00e9vr 2025."},{"key":"7333_CR9","unstructured":"CNEDIMTS-6266_FREESTYLE. LIBRE 2_20_octobre_2020_(6266)_avis.pdf. [cit\u00e9 3 janv 2025]. Disponible sur: https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CNEDIMTS-6266_FREESTYLE%20LIBRE%202_20_octobre_2020_(6266)_avis.pdf."},{"issue":"4","key":"7333_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4093\/dmj.2019.0121","volume":"43","author":"G Cappon","year":"2019","unstructured":"Cappon G, Vettoretti M, Sparacino G, Facchinetti A. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes Metab J ao\u00fbt. 2019;43(4):383\u201397. https:\/\/doi.org\/10.4093\/dmj.2019.0121. PubMed PMID: 31441246; PubMed Central PMCID: PMC6712232.","journal-title":"Diabetes Metab J ao\u00fbt"},{"issue":"10","key":"7333_CR11","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.numecd.2020.06.009","volume":"30","author":"A Cutruzzol\u00e0","year":"2020","unstructured":"Cutruzzol\u00e0 A, Irace C, Parise M, Fiorentino R, Pio Tripodi PF, Ungaro S, et al. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes. Nutr Metabolism Cardiovasc Dis sept. 2020;30(10):1800\u20135. https:\/\/doi.org\/10.1016\/j.numecd.2020.06.009.","journal-title":"Nutr Metabolism Cardiovasc Dis sept"},{"issue":"6","key":"7333_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1089\/dia.2023.0034","volume":"25","author":"B Guerci","year":"2023","unstructured":"Guerci B, Levrat-Guillen F, Vicaut E, De Pouvourville G, Detournay B, Emery C, et al. Reduced Acute Diabetes Events After FreeStyle Libre System Initiation in People 65 Years or Older with Type 2 Diabetes on Intensive Insulin Therapy in France. Diabetes Technol Ther juin. 2023;25(6):384\u201394. https:\/\/doi.org\/10.1089\/dia.2023.0034. PubMed PMID: 36944104.","journal-title":"Diabetes Technol Ther juin"},{"issue":"2","key":"7333_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.17925\/EE.2022.18.2.116","volume":"18","author":"L Prasad-Reddy","year":"2022","unstructured":"Prasad-Reddy L, Godina A, Chetty A, Isaacs D. Use of Continuous Glucose Monitoring in Older Adults: A Review of Benefits, Challenges and Future Directions. touchREV Endocrinol nov. 2022;18(2):116\u201321. https:\/\/doi.org\/10.17925\/EE.2022.18.2.116. PubMed PMID: 36694891; PubMed Central PMCID: PMC9835808.","journal-title":"touchREV Endocrinol nov"},{"issue":"8","key":"7333_CR14","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care ao\u00fbt. 2019;42(8):1593\u2013603. https:\/\/doi.org\/10.2337\/dci19-. 0028 PubMed PMID: 31177185; PubMed Central PMCID: PMC6973648.","journal-title":"Diabetes Care ao\u00fbt"},{"key":"7333_CR15","unstructured":"Arr\u00eat\u00e9 du 3 f\u00e9vrier 2025 portant. inscription du syst\u00e8me flash d\u2019autosurveillance du glucose interstitiel FREESTYLE LIBRE 2 PLUS de la soci\u00e9t\u00e9 ABBOTT France au titre I de la liste des produits et prestations remboursables pr\u00e9vue \u00e0 l\u2019article L. 165-1 du code de la s\u00e9curit\u00e9 sociale - L\u00e9gifrance. Disponible sur: https:\/\/www.legifrance.gouv.fr\/jorf\/id\/JORFTEXT000051132535. Cit\u00e9 19 f\u00e9vr 2025."},{"key":"7333_CR16","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes*. 13. Older adults: standards of care in diabetes\u20142026. Diabetes Care. 8 d\u00e9c 2025;49(Supplement_1):S277\u201396. https:\/\/doi.org\/10.2337\/dc26-S013.","DOI":"10.2337\/dc26-S013"},{"issue":"1","key":"7333_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2213-8587","volume":"11","author":"T Battelino","year":"2023","unstructured":"Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, Bergenstal RM, et al. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol janv. 2023;11(1):42\u201357. https:\/\/doi.org\/10.1016\/S2213-8587. (22)00319-9 PubMed PMID: 36493795.","journal-title":"Lancet Diabetes Endocrinol janv"},{"key":"7333_CR18","unstructured":"INESSS. Syst\u00e8me flash de surveillance du glucose (Freestyle libre). Rapport No. Disponible sur: https:\/\/www.inesss.qc.ca\/fileadmin\/doc\/INESSS\/Rapports\/Technologies\/INESSS_Avis_FreeStyle.pdf. Cit\u00e9 6 janv 2025."},{"issue":"5","key":"7333_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1177\/1932296817702657","volume":"11","author":"ML Litchman","year":"2017","unstructured":"Litchman ML, Allen NA. Real-Time Continuous Glucose Monitoring Facilitates Feelings of Safety in Older Adults With Type 1 Diabetes: A Qualitative Study. J Diabetes Sci Technol sept. 2017;11(5):988\u201395. doi:10.1177\/1932296817702657 PubMed PMID: 28376647; PubMed Central PMCID: PMC5950993.","journal-title":"J Diabetes Sci Technol sept"},{"issue":"3","key":"7333_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1177\/1932296817735123","volume":"12","author":"KD Barnard","year":"2018","unstructured":"Barnard KD, Kropff J, Choudhary P, Neupane S, Bain SC, Kapitza C, et al. Acceptability of Implantable Continuous Glucose Monitoring Sensor. J Diabetes Sci Technol mai. 2018;12(3):634\u20138. doi:10.1177\/1932296817735123 PubMed PMID: 28990436; PubMed Central PMCID: PMC6154244.","journal-title":"J Diabetes Sci Technol mai"},{"issue":"1","key":"7333_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s13098-023-01225-4","volume":"15","author":"SAO Leite","year":"2023","unstructured":"Leite SAO, Silva MP, Lavalle ACR, Bertogy MCV, Bastos M, Kuklik SCV, et al. Use of continuous glucose monitoring in insulin-treated older adults with type 2 diabetes. Diabetol Metabolic Syndrome 23 nov. 2023;15(1):240. https:\/\/doi.org\/10.1186\/s13098-023-01225-4.","journal-title":"Diabetol Metabolic Syndrome 23 nov"},{"key":"7333_CR22","doi-asserted-by":"publisher","first-page":"100382","DOI":"10.1016\/j.metop.2025.100382","volume":"27","author":"SF Alfadli","year":"2025","unstructured":"Alfadli SF, Alotaibi YS, Aqdi MJ, Almozan LA, Alzubaidi ZB, Altemani HA, et al. Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: A systematic review and meta-analysis. Metabol Open sept. 2025;27:100382. https:\/\/doi.org\/10.1016\/j.metop.2025.100382. PubMed PMID: 40791933; PubMed Central PMCID: PMC12337206.","journal-title":"Metabol Open sept"},{"issue":"10","key":"7333_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/dia.2019.0136","volume":"21","author":"MB Smith","year":"2019","unstructured":"Smith MB, Albanese-O\u2019Neill A, Macieira TGR, Yao Y, Abbatematteo JM, Lyon D, et al. Human Factors Associated with Continuous Glucose Monitor Use in Patients with Diabetes: A Systematic Review. Diabetes Technol Ther oct. 2019;21(10):589\u2013601. https:\/\/doi.org\/10.1089\/dia.2019.0136. PubMed PMID: 31335196.","journal-title":"Diabetes Technol Ther oct"},{"issue":"4","key":"7333_CR24","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1177\/1932296820932903","volume":"14","author":"RJ Galindo","year":"2020","unstructured":"Galindo RJ, Aleppo G, Klonoff DC, Spanakis EK, Agarwal S, Vellanki P, et al. Implementation of Continuous Glucose Monitoring in the Hospital: Emergent Considerations for Remote Glucose Monitoring During the COVID-19 Pandemic. J Diabetes Sci Technol 14 juin. 2020;14(4):822\u201332. \/1932296820932903 PubMed PMID: 32536205; PubMed Central PMCID: PMC7673156.","journal-title":"J Diabetes Sci Technol 14 juin"},{"issue":"10","key":"7333_CR25","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00125-024-06240-2","volume":"67","author":"G Maltese","year":"2024","unstructured":"Maltese G, McAuley SA, Trawley S, Sinclair AJ. Ageing well with diabetes: the role of technology. Diabetologia oct. 2024;67(10):2085\u2013102. https:\/\/doi.org\/10.1007\/s00125-024-06240-2. PubMed PMID: 39138689; PubMed Central PMCID: PMC11446974.","journal-title":"Diabetologia oct"},{"issue":"2","key":"7333_CR26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/ijem.ijem_153_21","volume":"25","author":"NKD Purnamayanti","year":"2021","unstructured":"Purnamayanti NKD, Wicaksana AL. Digital Health Services among Patients with Diabetes during the COVID-19 Pandemic: A Scoping Review. Indian J Endocrinol Metab. 2021;25(2):86\u201392. https:\/\/doi.org\/10.4103\/ijem.ijem_153_21. PubMed PMID: 34660235; PubMed Central PMCID: PMC8477741.","journal-title":"Indian J Endocrinol Metab"},{"issue":"7","key":"7333_CR27","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/jgs.18341","volume":"71","author":"AS Boureau","year":"2023","unstructured":"Boureau AS, Guyomarch B, Gourdy P, Allix I, Annweiler C, Cervantes N, et al. Nocturnal hypoglycemia is underdiagnosed in older people with insulin-treated type 2 diabetes: The HYPOAGE observational study. J Am Geriatr Soc juill. 2023;71(7):2107\u201319. https:\/\/doi.org\/10.1111\/jgs.18341. PubMed PMID: 36965179.","journal-title":"J Am Geriatr Soc juill"},{"issue":"2","key":"7333_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/1932296815602905","volume":"10","author":"AM G\u00f3mez","year":"2015","unstructured":"G\u00f3mez AM, Umpierrez GE, Mu\u00f1oz OM, Herrera F, Rubio C, Aschner P, et al. Continuous Glucose Monitoring Versus Capillary Point-of-Care Testing for Inpatient Glycemic Control in Type 2 Diabetes Patients Hospitalized in the General Ward and Treated With a Basal Bolus Insulin Regimen. J Diabetes Sci Technol 31 ao\u00fbt. 2015;10(2):325\u20139. doi:10.1177\/1932296815602905 PubMed PMID: 26330394; PubMed Central PMCID: PMC4773955.","journal-title":"J Diabetes Sci Technol 31 ao\u00fbt"},{"issue":"5","key":"7333_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/dme.12713","volume":"32","author":"JP New","year":"2015","unstructured":"New JP, Ajjan R, Pfeiffer AFH, Freckmann G. Continuous glucose monitoring in people with diabetes: the randomized controlled Glucose Level Awareness in Diabetes Study (GLADIS). Diabet Med mai. 2015;32(5):609\u201317. https:\/\/doi.org\/10.1111\/dme.12713. PubMed PMID: 25661981.","journal-title":"Diabet Med mai"},{"issue":"1","key":"7333_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2337\/dc24","volume":"48","author":"A Christiaens","year":"2025","unstructured":"Christiaens A, Boureau AS, Guyomarch B, de Decker L, Boland B, Hadjadj S, et al. Diabetes Overtreatment and Hypoglycemia in Older Patients With Type 2 Diabetes on Insulin Therapy: Insights From the HYPOAGE Cohort Study. Diabetes Care 1 janv. 2025;48(1):61\u20136. https:\/\/doi.org\/10.2337\/dc24-. 1058 PubMed PMID: 39172937.","journal-title":"Diabetes Care 1 janv"},{"issue":"6","key":"7333_CR31","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.clnu.2012.05.008","volume":"31","author":"K Norman","year":"2012","unstructured":"Norman K, Stob\u00e4us N, Pirlich M, Bosy-Westphal A. Bioelectrical phase angle and impedance vector analysis\u2013clinical relevance and applicability of impedance parameters. Clin Nutr d\u00e9c. 2012;31(6):854\u201361. https:\/\/doi.org\/10.1016\/j.clnu.2012.05.008. PubMed PMID: 22698802.","journal-title":"Clin Nutr d\u00e9c"},{"issue":"36","key":"7333_CR32","doi-asserted-by":"publisher","first-page":"e8021","DOI":"10.1097\/MD.0000000000008021","volume":"96","author":"Y Huang","year":"2017","unstructured":"Huang Y, Heng C, Wei J, Jing X, Wang X, Zhao G, et al. Influencing factors of glycemic variability in hospitalized type 2 diabetes patients with insulin therapy: A Strobe-compliant article. Med (Baltimore) sept. 2017;96(36):e8021. https:\/\/doi.org\/10.1097\/MD.0000000000008021. PubMed PMID: 28885369; PubMed Central PMCID: PMC6392839.","journal-title":"Med (Baltimore) sept"},{"issue":"3","key":"7333_CR33","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/19322968241234651","volume":"18","author":"C Price","year":"2024","unstructured":"Price C, Callahan KE, Aloi JA, Usoh CO. Continuous Glucose Monitoring in Older Adults: What We Know and What We Have Yet to Learn. J Diabetes Sci Technol 7 mars. 2024;18(3):577\u201383. doi:10.1177\/19322968241234651 PubMed PMID: 38454549; PubMed Central PMCID: PMC11089865.","journal-title":"J Diabetes Sci Technol 7 mars"},{"issue":"4","key":"7333_CR34","doi-asserted-by":"publisher","first-page":"e287","DOI":"10.1016\/S2666-7568","volume":"5","author":"K Nicholson","year":"2024","unstructured":"Nicholson K, Liu W, Fitzpatrick D, Hardacre KA, Roberts S, Salerno J, et al. Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review. Lancet Healthy Longev avr. 2024;5(4):e287\u201396. https:\/\/doi.org\/10.1016\/S2666-7568. (24)00007-2 PubMed PMID: 38452787.","journal-title":"Lancet Healthy Longev avr"},{"issue":"3","key":"7333_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s41999-021-00479-3","volume":"12","author":"F Pazan","year":"2021","unstructured":"Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med juin. 2021;12(3):443\u201352. https:\/\/doi.org\/10.1007\/s41999-021-00479-3. PubMed PMID: 33694123; PubMed Central PMCID: PMC8149355.","journal-title":"Eur Geriatr Med juin"},{"issue":"6","key":"7333_CR36","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s13300-025-01720-z","volume":"16","author":"A Wilson","year":"2025","unstructured":"Wilson A, Morrison D, Sainsbury C, Jones G. Narrative Review: Continuous Glucose Monitoring (CGM) in Older Adults with Diabetes. Diabetes Ther juin. 2025;16(6):1139\u201354. https:\/\/doi.org\/10.1007\/s13300-025-01720-z. PubMed PMID: 40238078; PubMed Central PMCID: PMC12085541.","journal-title":"Diabetes Ther juin"},{"issue":"1","key":"7333_CR37","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/19322968231200847","volume":"18","author":"T Tian","year":"2024","unstructured":"Tian T, Aaron RE, Seley JJ, Longo R, Nayberg I, Umpierrez GE, et al. Use of Continuous Glucose Monitors Upon Hospital Discharge of People With Diabetes: Promise, Barriers, and Opportunity. J Diabetes Sci Technol janv. 2024;18(1):207\u201314. 19322968231200847 PubMed PMID: 37784246; PubMed Central PMCID: PMC10899827.","journal-title":"J Diabetes Sci Technol janv"},{"key":"7333_CR38","doi-asserted-by":"publisher","unstructured":"Kumar N, Knight AM, Demidowich AP, Stanback CF, Bashura H, Hussain Q et al. Implementing a Continuous Glucose Monitoring Hospital Discharge Program: Strategies and Best Practices. J Diabetes Sci Technol. 2025;19322968251370754. https:\/\/doi.org\/10.1177\/19322968251370754. PubMed PMID: 40958410.","DOI":"10.1177\/19322968251370754"},{"issue":"1","key":"7333_CR39","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12902-018-0239-1","volume":"18","author":"J Lawton","year":"2018","unstructured":"Lawton J, Blackburn M, Allen J, Campbell F, Elleri D, Leelarathna L, et al. Patients\u2019 and caregivers\u2019 experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study. BMC Endocr Disord 20 f\u00e9vr. 2018;18(1):12. https:\/\/doi.org\/10.1186\/s12902-018-0239-1. PubMed PMID: 29458348; PubMed Central PMCID: PMC5819241.","journal-title":"BMC Endocr Disord 20 f\u00e9vr"},{"issue":"5","key":"7333_CR40","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1177\/19322968221149040","volume":"18","author":"AR Kahkoska","year":"2024","unstructured":"Kahkoska AR, Shah KS, Kosorok MR, Miller KM, Rickels M, Weinstock RS, et al. Estimation of a Machine Learning-Based Decision Rule to Reduce Hypoglycemia Among Older Adults With Type 1 Diabetes: A Post Hoc Analysis of Continuous Glucose Monitoring in the WISDM Study. J Diabetes Sci Technol sept. 2024;18(5):1079\u201386. doi:10.1177\/19322968221149040 PubMed PMID: 36629330; PubMed Central PMCID: PMC11418529.","journal-title":"J Diabetes Sci Technol sept"},{"issue":"5","key":"7333_CR41","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1177\/19322968241269927","volume":"18","author":"T Glatzer","year":"2024","unstructured":"Glatzer T, Ringemann C, Militz D, Mueller-Hoffmann W. Concept and Implementation of a Novel Continuous Glucose Monitoring Solution With Glucose Predictions on Board. J Diabetes Sci Technol sept. 2024;18(5):1004\u20138. doi:10.1177\/19322968241269927 PubMed PMID: 39158990; PubMed Central PMCID: PMC11418471.","journal-title":"J Diabetes Sci Technol sept"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-07333-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07333-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-07333-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:14:52Z","timestamp":1781640892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-07333-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7333"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-07333-w","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was an observational study based on routine clinical care conducted in an acute geriatric unit. Continuous glucose monitoring (CGM) was used in accordance with current international and national recommendations, including those of the American Diabetes Association (ADA; Diabetes Care, Chap.\u00a013: Older Adults), the European Geriatric Medicine Society (EuGMS; Bourdel-Marchasson I. et al., Aging Clinical and Experimental Research, 2023), and the Soci\u00e9t\u00e9 Francophone du Diab\u00e8te (SFD).In this context, the use of CGM was part of standard care in our department for insulin-treated older adults, and no additional intervention, modification of treatment strategy, or randomization was performed for research purposes. The study consisted solely of a retrospective analysis of routinely collected clinical and CGM data. Although CGM had been routinely used in the unit for several years, these data had not previously been analyzed for research purposes.According to French regulations governing observational studies based exclusively on routine care and anonymized data (loi Jard\u00e9), formal approval from a local ethics committee or institutional review board was not required.In accordance with French regulations on personal data protection, the study was declared and conducted under the Commission Nationale de l\u2019Informatique et des Libert\u00e9s (CNIL) reference methodology MR-004, which governs research based on the retrospective analysis of routinely collected health data (CNIL registration number: 24501189). Oral informed consent was obtained from all participants after provision of written study information.This study was conducted in full compliance with the principles of the Declaration of Helsinki, and investigators involved in the study were trained in Good Clinical Practice.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"578"}}